Drug softens ovaries to boost fertility in older rodents

A new experimental treatment reduced stiffness in the ovaries of older mice and rats, leading to higher conception rates and larger litters. Researchers say the approach could one day help women conceive later in life, though human trials are still needed.

Scientists at Huazhong University of Science and Technology tested an experimental drug that blocks the protein interleukin-11. Injections given twice a week for four weeks to 36-week-old mice made their ovaries 36 percent less stiff.

The treated mice doubled their conception rate from 25 percent to 50 percent and raised average litter size from three to five pups. Similar results appeared in rats, where conception rose from 20 percent to 50 percent and litters grew from one to five pups.

The team also created mice unable to respond to interleukin-11. These animals showed reduced ovarian stiffness and ovulated more than untreated controls as they aged. Experts note the drug must now be tested for safety and effectiveness in people before any clinical use.

Articoli correlati

A single mRNA injection can halve the rate of chromosome errors in human eggs from older women, according to new research presented at a London conference. The treatment targets a protein deficiency that contributes to aneuploidy, a common cause of IVF failure and miscarriage. Researchers say the approach shows promise for improving fertility outcomes.

Riportato dall'IA

New research in mice suggests that ovaries undergo significant changes after reproductive decline, potentially contributing to inflammation. Scientists found increased immune cell activity in aged ovaries.

An experimental therapy called VERVE-102 lowered LDL cholesterol by up to 62 percent after a single dose in an early safety study. The results come from a Phase I trial involving 35 patients with high cholesterol or early cardiovascular disease. Data were published this week in the New England Journal of Medicine.

Riportato dall'IA Verificato

Researchers from the University of Barcelona and the University of Oregon report that short DNA molecules known as polypurine reverse Hoogsteen hairpins (PPRHs) suppressed the PCSK9 gene and reduced blood cholesterol in a mouse model. In transgenic mice carrying the human PCSK9 gene, a single injection of one candidate (HpE12) cut plasma PCSK9 by 50% and total cholesterol by 47% three days later, according to findings published in Biochemical Pharmacology.

An antioxidant called L-ergothioneine, found in certain mushrooms, reduced period pain in a small study of 40 women. Participants took a daily 120-milligram supplement over three menstrual cycles, reporting lower pain scores compared to a placebo group. The findings suggest it targets oxidative stress in uterine cells.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta